The report will be delivered in 2-3 business days.

Gynecology Drugs Global Market Report 2021 - By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change

Starting Price : $5000.00 | Pages : 150 | Published : May 2021 | SKU CODE : | Format :


The gynecology drugs market consists of sales of gynecology drugs services by entities (organizations, sole traders, and partnerships) that manufacture gynecology drugs which are used to treat gynecological diseases which includes conditions affecting the uterus, ovaries, and their appendages.

The main types of therapeutics in gynecology drugs are hormonal therapy and non-hormonal therapy. Hormonal therapy is a treatment that adds, blocks or removes hormones to slow or stop the growth of cancer cells that need hormones to grow. Non hormonal therapy involves the usage of anti- infective, anti-inflammatory agents, lubricants, moistures, antidepressants, gabapentin, clonidine and others. Gynecology drugs are used for gynecology cancers, menopausal disorder, polycystic ovary syndrome, contraception and others and distributed through hospital pharmacies, retail pharmacies and online pharmacies.

The global gynecology drugs market is expected to grow from $22.22 billion in 2020 to $24.68 billion in 2021 at a compound annual growth rate (CAGR) of 11.07%. The growth is mainly due to the increase in gynecological disorders among women and rising cases of gynecological cancer. The gynecology drugs market is expected to reach $31.21 billion in 2025 at a CAGR of 6.05%.

The rise in number of women suffering from ovarian cancer would drive the growth of the global gynecological drugs market. For instance, according to Globocan, it is estimated that the global incidence of ovarian cancer will increase from 295,414 in 2018 to 434,184 by 2040. The increasing incidence of ovarian cancer would boost the market for gynecological drugs in the forecast period.

Alternative treatment methods and natural remedies are increasingly becoming popular globally which is expected to have a negative impact on the revenues of gynecological drugs companies. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, Ayurvedic medicine, an ancient Indian system of medicine uses range of techniques and treatments for gynecological cancer. Many of herbs used in Ayurveda have anti-cancer properties, example Curcumin, Holy Basil are said to inhibit the growth of cancerous cells and Ayurvedic gynecological procedures like Agnikarma helps treat cervical erosion. This growing adoption of alternative treatments is expected to have a negative impact on the growth of the market.

Drug manufacturers are investing in developing personalized cancer vaccines, including gynecological cancers, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients. For instance, in 2016, Merck, an American pharmaceutical company collaborated with Moderna Therapeutics, an American biotech company pioneer of messenger RNA Therapeutics to develop and commercialize novel messenger RNA (mRNA)-based personalized cancer vaccines. In 2019, Moderna announced the result from the ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumors. The results were positive when mRNA mRNA personalized cancer vaccine (PCV) mRNA-4157, given alone or in combination with Merck pembrolizumab (KEYTRUDA®). Currently the vaccine is in phase 2 clinical trial.

In January 2020, India based capital market company True North announced the acquisition of India based Glenmark Pharmaceuticals Ltd gynecology business in India and Nepal for $16.2 million (INR 115 crore). Through this acquisition, True North aims at further growing the gynecology portfolio of Glenmark and expanding presence in multiple geographies.

Major players in the gynecology drugs market are Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co. Inc., Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc., Lupin Pharmaceuticals Inc., Ferring Holding SA, Johnson & Johnson, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., and Sanofi.

North America was the largest region in the gynecology drugs market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the gynecology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gynecology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global gynecology drugs market is segmented -

1) By Therapeutics: Hormonal Therapy, Non-Hormonal Therapy

2) By Indication: Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Others

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Table Of Contents

    1. Executive Summary

    2. Gynecology Drugs Market Characteristics

    3. Gynecology Drugs Market Trends And Strategies

    4. Impact Of COVID-19 On Gynecology Drugs

    5. Gynecology Drugs Market Size And Growth

    5.1. Global Gynecology Drugs Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Gynecology Drugs Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Gynecology Drugs Market Segmentation

    6.1. Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hormonal Therapy

    Non-Hormonal Therapy

    6.2. Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Gynecology Cancers

    Menopausal Disorder

    Polycystic Ovary Syndrome

    Contraception

    Others

    6.3. Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Gynecology Drugs Market Regional And Country Analysis

    7.1. Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Gynecology Drugs Market

    8.1. Asia-Pacific Gynecology Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Gynecology Drugs Market

    9.1. China Gynecology Drugs Market Overview

    9.2. China Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Gynecology Drugs Market

    10.1. India Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Gynecology Drugs Market

    11.1. Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Gynecology Drugs Market

    12.1. Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Gynecology Drugs Market

    13.1. Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Gynecology Drugs Market

    14.1. South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Gynecology Drugs Market

    15.1. Western Europe Gynecology Drugs Market Overview

    15.2. Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Gynecology Drugs Market

    16.1. UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Gynecology Drugs Market

    17.1. Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Gynecology Drugs Market

    18.3. France Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Gynecology Drugs Market

    19.1. Eastern Europe Gynecology Drugs Market Overview

    19.2. Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Gynecology Drugs Market

    20.1. Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Gynecology Drugs Market

    21.1. North America Gynecology Drugs Market Overview

    21.2. North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Gynecology Drugs Market

    22.1. USA Gynecology Drugs Market Overview

    22.2. USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Gynecology Drugs Market

    23.1. South America Gynecology Drugs Market Overview

    23.2. South America Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Gynecology Drugs Market

    24.1. Brazil Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Gynecology Drugs Market

    25.1. Middle East Gynecology Drugs Market Overview

    25.2. Middle East Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Gynecology Drugs Market

    26.1. Africa Gynecology Drugs Market Overview

    26.2. Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Gynecology Drugs Market Competitive Landscape And Company Profiles

    27.1. Gynecology Drugs Market Competitive Landscape

    27.2. Gynecology Drugs Market Company Profiles

    27.2.1. Hoffmann-La Roche Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Merck & Co., Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Allergan

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AstraZeneca

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Gynecology Drugs Market

    29. Gynecology Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: China, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: India, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Japan, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: Australia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: Indonesia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: South Korea, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Western Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: UK, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Germany, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: France, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Eastern Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Russia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: North America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: USA, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Brazil, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Middle East, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Africa, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Hoffmann-La Roche Ltd. Financial Performance
  • Table 28: Pfizer Inc Financial Performance
  • Table 29: Merck & Co., Inc. Financial Performance
  • Table 30: Allergan Financial Performance
  • Table 31: AstraZeneca Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Gynecology Drugs Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Gynecology Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Gynecology Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: China, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: India, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Japan, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: Australia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: Indonesia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: South Korea, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Western Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: UK, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Germany, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: France, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Eastern Europe, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Russia, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: North America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: USA, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South America, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Brazil, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Middle East, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Africa, Gynecology Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Hoffmann-La Roche Ltd. Financial Performance
  • Figure 28: Pfizer Inc Financial Performance
  • Figure 29: Merck & Co., Inc. Financial Performance
  • Figure 30: Allergan Financial Performance
  • Figure 31: AstraZeneca Financial Performance
Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Acne Drugs Market - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics, Others), By Therapeutic Class (Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Acne Global Market Report 2021 - By Type (Inflammatory Acne, Non-Inflammatory Acne), By End User (Hospitals & Clinics, Pharmacies & Drug Stores, Ambulatory Surgical Centres), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide), COVID-19 Impact And Recovery
View Report
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2021 - By Product (Adalimumab Biosimilars (Exemptia, Mabura, Hyrimoz, Hadlima, Abrilada, Others), Infliximab Biosimilars (Inflectra, Renflexis, Ixifi, Avsola), Cipleumab (Erelzi, Eticovo)), By Application (Crohn’s Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Anti-Hypertensive Drugs Global Market Report 2021 - By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare), COVID-19 Impact And Recovery
View Report
Antibody Drug Conjugates Global Market Report 2021 - By Type (Monoclonal Antibodies, Linker, Drug/Toxin), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), By Product (Adcertis, Kadcyla), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology), By End User (Hospital, Clinics), COVID-19 Growth And Change
View Report
Antidepressants Global Market Report 2021 - By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)), By Drug Class (Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants), By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder), COVID-19 Implications And Growth
View Report
Colorectal Cancer Drugs Global Market Report 2021 - By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators), By Distribution Channels (Hospitals Pharmacies, Retail Pharmacies), By Class (Immunotherapy, Chemotherapy), COVID-19 Impact And Recovery
View Report
Antiglaucoma Drugs Global Market Report 2021 - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma), By Type (Hospital Prescription Drugs, Over-the-counter Drugs), COVID-19 Impact And Recovery
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)